Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mbale Clinical Research Institute (MCRI) is a premier clinical research organization based in Mbale, Uganda, specializing in high-quality clinical trials and health research within sub-Saharan Africa. Affiliated with the Mbale Regional Referral Hospital and the Uganda Ministry of Health, the institute focuses on addressing major public health challenges including malaria, tuberculosis, HIV/AIDS, and neonatal sepsis. MCRI provides comprehensive infrastructure for Phase I through IV clinical trials, supported by a GCLP-compliant laboratory and a dedicated research ward. The organization is renowned for its leadership in large-scale pediatric trials that have directly informed World Health Organization (WHO) treatment guidelines. Through strategic partnerships with institutions like Imperial College London and the University of Oxford, MCRI continues to advance medical science and improve health outcomes in resource-limited settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mbale Clinical Research Institute.